Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes
Value in Health · 2026
DOI: 10.1016/j.jval.2026.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026. Verfasst von Melanie Lloyd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and Policy Evaluation Research, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia; Allergy Immunology, Mur…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 2, Prenatal Care, Life Style. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Future Fund, National Heart Foundation of Australia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVES: To evaluate the population net health benefit and distributional health impact across socioeconomic subgroups when considering alternative target populations for implementing antenatal lifestyle interventions in Australia. METHODS: Differences in the distributions of health within population subgroups defined by Socioeconomic Index for Areas quintiles were compared for standard care (no routine antenatal lifestyle intervention) versus subsidized provision to (1) all pregnant women, (2) women with body mass index (BMI) ≥ 25, (3) women aged ≥ 30 years, or (4) women giving birth within the public health system. Distributional cost-effectiveness analysis of the alternative implementation strategies was conducted to model the impact on disease incidence (gestational and type-2 diabetes), direct healthcare costs, opportunity costs, mortality and quality-adjusted life-years for socioeconomic subgroups. Data were obtained from national statistics, registries and the literature. Value judgements regarding aversion to social inequality in health were captured using the Atkinson index. Extensive sensitivity analyses were conducted. RESULTS: At an opportunity-cost threshold of AU$31 157 (2024 prices), all implementation strategies improved overall population health and reduced health inequality compared with current standard care. Provision to women with a BMI ≥ 25 generated the highest population net health benefit, whereas provision only within the public health system generated the greatest reduction in health inequality. Sensitivity analyses did not materially change these findings. CONCLUSIONS: Among the targeted strategies evaluated, limiting implementation to women with BMI ≥ 25 is likely to result in the greatest incremental population net health gains and is the preferred strategy when trade-offs between efficiency and health equity are considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Economics and Policy Evaluation Research, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia; Allergy Immunology, Murdoch Children's Research Institute, Parkville, Victoria, Australia. El…
- Health Economics and Policy Evaluation Research, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
- Health Economics and Policy Evaluation Research, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Public Health a…
- School of Public Health, University of Technology Sydney, Sydney, New South Wales, Australia.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; School of Public Health, University of Technology Sydney, Sydney, New South Wales, Australia.
- Centre for Health Economics, University of York, York, England, UK; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Förderung
- Medical Research Future Fund
- National Heart Foundation of Australia
Zitieren
APA
Lloyd, M., Rodda, S., Morton, J., Hu, Y., Callander, E., Cookson, R., Teede, H., & Ademi, Z. (2026). Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes. Value in Health. https://doi.org/10.1016/j.jval.2026.03.005
Vancouver
Lloyd M, Rodda S, Morton J, Hu Y, Callander E, Cookson R, et al. Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes. Value in Health. 2026. doi:10.1016/j.jval.2026.03.005
BibTeX
@article{Lloyd2026,
author = {Lloyd, Melanie and Rodda, Sheridan and Morton, Jedidiah and Hu, Yanan and Callander, Emily and Cookson, Richard and Teede, Helena and Ademi, Zanfina},
title = {Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes},
journal = {Value in Health},
year = {2026},
doi = {10.1016/j.jval.2026.03.005}
}
EUVIMED